Speakers

Paul Nioi

VP, Discovery & Translational Research

Alnylam Pharmaceuticals

Dee Datta

CEO

Switch Therapeutics

Ulrik Lytt Rahbek

VP of Partnerships RNA & Gene Therapies

Novo Nordisk

Dan Staner

VP, General Manager Germany & Switzerland & Head of Middle East Region

Moderna

Richard Klar

CRO

Secarna

Tamar Grossman

VP, Global Head of RNA & Targeted Therapeutics

Johnson & Johnson

Morten Lindow

Co-Founder & Senior Lead RNAHub

Roche

Marie Wikstrom-Lindholm

CSO

Silence Therapeutics

Jacques Dumas

CSO

Arrakis Therapeutics

Nathaniel Wang

CEO

Replicate Bioscience

Ivan Burkov

Partner

INKEF Capital

Marie-Hélène Leopold

CCO

AGS Therapeutics

Claire Tardiveau

Strategic Partnerships & Collaborations Lead

Sanofi

Christalyn Rhodes

AVP - Genetic Medicine -External Partnerships and Academic Collaborations

Eli Lilly

Sudhir Agrawal

President & Founder

Arnay Sciences

John Androsavich

VP, Business Development, Head of In Vivo Biotherapeutics

Ginkgo Bioworks

Ankan Banerjee

Principal Investigator

The Philipp University of Marburg

Julian Bertschinger

Global Head External Innovation DPDS

Johnson & Johnson

Steven Biesmans

Principal

UCB

Marcel Blommers

CSO

Saverna Therapeutics

Bernhard Bobusch

CEO

FDX

Leigh Brody

Investment Manager

Albion VC

Phil Challis

VP Manufacturing Services

etherna

Otilia Cheregi

Principal Investigator

TATAA Biocenter

Peter Chu

CEO

Eclipse Bio

Amanda Dupont

Senior Principal Scientist

Roche

Gabriela Ecco

Senior Associate

+ND Capital

Tomaz Einfalt

Principle Investigator II / Project Team Lead xRNA

Novartis

Bettina Ernst

Director

BERNINA BioInvest

Ramon Espinoza

Business Development Manager

Sylentis

Brendan Fish

Director of Biologics & RNA Centre of Excellence

Centre for Process Innovation

Juan Florez

R&D Scientist

Genedata

Jacqueline Fok

Investment VP Life Sciences

Softbank Vision Fund

Miroslav Gaparek

CEO

Sensible Biotechnologies

Mathieu Ghadanfar

Ziphius

Ziphius

Anne Grahl

Associate

Pureos Bioventures

Gal Gur

VP Business Development

Anima Biotech Inc.

Thomas Guyon

Product Marketing Manager

Quantoom Biosciences

Nagy Habib

Head of R&D

MiNA Therapeutics

Matthias Hackl

CEO

TAmiRNA

Stefan Haemmig

Principal Investigator II / Project Team Lead xRNA

Novartis

François Hallac

Post-Doc Manufacturing Systems

King's College London

Trevor Hallam

CSO

Sail Biomedicines

Sophie Hammer

Senior Manager Strategic & Technical Marketing

Evonik

Lorna Harries

CSO

Senisca

Hans Huber

CEO

Biomay

Michael Huebner

Country Lead Switzerland

Johnson & Johnson Innovation

Ike James

Head of Technology Transfer

Medicines Patent Pool

Lakmal Jayasinghe

SVP - R&D Biologics

Oxford Nanopore Technologies

Lloyd Jeffs

Senior Director of Biopharma Services

Cytiva

Hyun-Bae Jie

CEO & CTO

Levatio Therapeutics

Imelda Juniarsih

Investment Director

Pioneer Group

Michael Keller

Expert Scientist

Roche

Ben Knappett

Market Manager – LNPs

Unchained Labs

Hendrik Knoetgen

Head of Genomic Medicine & Targeted Therapeutics

Roche

Marek Kozlowski

Senior Investment Director

NRW Ventures

Marek Kudla

Director of Bioinformatics

Ardigen

Michael Kyriakides

Investment Partner

Syncona

Sujin Lee

Professor

Emory University

Nicholas Lench

Executive Director

The MRC Nucleic Acid Therapy Accelerator

Beatriz Llamusi

CEO & Co-Founder

Arthex Biotech

César López-Camacho

Principal Investigator

University of Oxford

Harris Makatsoris

Professor of Sustainable Manufacturing Systems

King's College London

Bogdan Mateescu

Group Leader

University of Zürich

Antoine Maupu

VP of Manufacturing

Moderna

Gisela Mautner

CEO

Noxopharm

Keith Mayl

ALS Strategy Lead | Senior Clinical Development Lead

Servier

Zdravka Medarova

Founder & CTO

TransCode Therapeutics

Sonja Merkas

Freelance Manager

Freelance

Tilo Netzer

Head of Commercial Development mRNA Business Uni

Lonza

Jade Osei-Tutu

Senior Conference Director

LSX

Søren Ottosen

VP

Sixfold Bioscience

Samir Ounzain

CEO & Scientific Co-Founder

HAYA Therapeutics SA

David Oxley

CBO

BIORCHESTRA

Can Ozbal

CEO

Momentum Biotechnologies

Covadonga Paneda

COO

Altamira Therapeutics

Riccardo Panella

CSO

Resalis Therapeutics

Tej Panesar

Partner

Prism Ventures

Lijuan Pang

Project Director, Discovery Services

WuXi AppTec

Steve Pascolo

Researcher (Former Founder, CureVac)

University Hospital of Zurich

Ajan Reginald

CEO

Roquefort Therapeutics

Hagen Richter

Director Nucleic Acid Research

Wacker

Giovanni Rizzo

Partner Biotech Fund

Indaco Venture Partners

Michele Rubino

CBO

Primrose Bio

Felix Schumacher

Program Leader Targeted Therapeutics

Roche

Alexander Schwenger

Head of LNP Process Development

Lonza

Michael Shpigelmacher

CEO

Bionaut Labs

David Sokolowski

Global Workflow Manager, Nucleic Acid Therapeutics

Cytiva

Walter Stockinger

Managing Partner

Hadean Ventures

Hiroki Takai

Director

Global Brain

Disa Tehler

Head of RNA Therapeutics

Abzu

Patrick Thiaville

CTO Nucleic Acids

Exothera

Thomas Thum

CSO & Founder

Cardior Pharmaceuticals

John Todd

Business Development Director

Intertek

Dong Kyu Uh

President

Daewoong Innovation Holdings

Michael Van Der Horst

Head of BioProcess Development

Wacker

Manuel Vega

CEO

AGS Therapeutics

Paul Vernooij

Investment Manager

BOM Brabant Ventures

Ming Wang

Business Development Manager

Genedata

Javier Warren

Product Manager

Certest Biotec S.L.

Renee Williams

Managing Partner

Williams Biotech Consulting, LLC

Dominik Witzigmann

CEO

Nanovation Therapeutics

Joo-Sung Yang

SVP

ST Pharm

Duygu Yilmaz

Associate Director for Lead Development

OchreBio

Dimitar Yonchev

Data Engineer

Roche

Helge Zieler

CEO

Primrose Bio

Mina Zion

Director

Weill Cornell Medicine